SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0000950170-24-073737
Filing Date
2024-06-14
Accepted
2024-06-14 16:30:48
Documents
14

Document Format Files

Seq Description Document Type Size
1 S-1 apvo-2024-s1_-_june_offe.htm S-1 897535
2 EX-4.19 apvo-ex4_19.htm EX-4.19 155865
3 EX-4.20 apvo-ex4_20.htm EX-4.20 157829
4 EX-4.21 apvo-ex4_21.htm EX-4.21 307949
5 EX-4.22 apvo-ex4_22.htm EX-4.22 157638
6 EX-5.1 apvo-ex5_1.htm EX-5.1 32550
7 EX-23.1 apvo-ex23_1.htm EX-23.1 3862
8 EX-FILING FEES apvo-exfiling_fees.htm EX-FILING FEES 103831
9 GRAPHIC img57496738_0.jpg GRAPHIC 5454
10 GRAPHIC img160838558_0.jpg GRAPHIC 2340
11 GRAPHIC img230728392_0.jpg GRAPHIC 6733
12 GRAPHIC img230728392_1.jpg GRAPHIC 60914
13 GRAPHIC img230728392_2.jpg GRAPHIC 528046
14 GRAPHIC img230728392_3.jpg GRAPHIC 4584
  Complete submission text file 0000950170-24-073737.txt   2656056
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-280226 | Film No.: 241045345
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)